HealthTree Logo
search more_vert
person Sign In / Create Account
All About Bispecific Antibodies for CLL with Dr. Adam Kittai
All About Bispecific Antibodies for CLL with Dr. Adam Kittai image
Adult CLL Chapter
event May 13, 2024 / 01:00PM - 02:00PM EDT
Can't make it to the event?
We send a recording to all registered participants of the event!

Event Description

What are bispecific antibodies, and when are they used in CLL treatment? How are bispecific antibodies administered, and what are the potential side effects? Join the group discussion with Dr. Adam Kittai, CLL specialist from Mt. Sinai School of Medicine, to discuss this important topic! 

Schedule & Agenda

The panelist Megan Heaps
1:00 PM
Megan Heaps

Megan introduces the agenda of the event and featured speaker Dr. Adam Kittai. 

The panelist Adam Kittai, MD
1:05 PM
Adam Kittai, MD

 Dr. Kittai shares what bispecific antibodies are and describes their use in CLL treatment.

The panelist Audience
Questions and Answers
1:35 PM

Type your questions in the chat and Dr. Kittai will answer them!

Speakers & Moderators

The panelist Adam Kittai, MD
Adam Kittai, MD

Dr. Adam Kittai is a hematologist who specializes in the treatment of chronic lymphocytic leukemia (CLL) and Richter’s syndrome. He is passionate about guiding every one of his patients through their treatment process, personalizing care to each patient’s individual needs. Furthermore, he enjoys developing novel therapies and optimizing regimens. He has the opportunity to work with cutting-edge technologies and the ability to enroll patients in clinical trials. It’s exciting for him to have access to these tools because they allow him the ability to provide the best care to his patients. In the CLL group, he specifically has an interest in developing targeted and cellular therapies to treat this disease. He also works closely with the basic science labs to translate medical advances rapidly from bench to bedside. He is a member of various professional organizations, including the American Society of Hematology, the American Society of Clinical Oncology, and the American Association for Cancer Research.

Read Bio
The panelist Megan Heaps
Megan Heaps

Megan joined HealthTree as the Program Manager for CLL in 2022. She is the daughter of a blood cancer patient and has found a passion for helping support patients and caregivers to advance research for their cure and improve their quality of life.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.


Get In Touch With Us




Get the latest thought leadership on Chronic Lymphocytic Leukemia delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Chronic Lymphocytic Leukemia Newsletter" for Chronic Lymphocytic Leukemia news, life with Chronic Lymphocytic Leukemia stories, Chronic Lymphocytic Leukemia clinical trials, Chronic Lymphocytic Leukemia 101 articles and events with Chronic Lymphocytic Leukemia experts.

Thanks to our HealthTree Community for Chronic Lymphocytic Leukemia Sponsors:


Follow Us

facebook twitter